Bio-Techne Corp. vs Eli Lilly & Co.
TECH vs LLY — side-by-side comparison from reported financials. TECH leads 2, LLY leads 10 of 12 comparable metrics.
Bio-Techne Corp.
TECH · Healthcare
$72.44-0.01%Strong
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | TECH | LLY |
|---|---|---|
| Price | $72.44 | $1 177.20 |
| Market cap | $11.4B | $1.05T |
| Revenue (TTM) | $1.22B | $79.7B |
| Revenue growth | +2.3% | +31.7% |
| Net margin | 15.0% | 33.5% |
| Free cash flow | $263M | $18.2B |
| Net cash (debt) | ($23.6M) | ($35.2B) |
| 1-year price return | +20.9% | +37.6% |
| P/E | 62.5 | 41.6 |
| P/E vs own history (cheap-side %) | 14% | 88% |
| Dividend yield | 0.44% | 0.52% |
| Return on equity | 9% | 93% |
| Altman Z-score | 15.94 | 7.10 |
| CV checks passed | 8 of 11 | 11 of 11 |
| Employees | 3,000 | 50,000 |
Full résumé-style profiles: TECH CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.